19 research outputs found
MemĂłria: uma questĂŁo de poder (Entrevista de Maria LĂșcia Montes)
A professora doutora Maria LĂșcia Montes, antropĂłloga do Departamento de Antropologia da Universidade de SĂŁo Paulo (USP), dedica-se Ă pesquisa histĂłrica por meio do resgate da memĂłria. Em outubro de 2006, ela fez conferĂȘncia em Manaus, no 2.Âș SeminĂĄrio Cultura Popular, PatrimĂŽnio Imaterial e Cidades, promovido pelo Departamento de Antropologia da Ufam, sob a coordenação do professor doutor SĂ©rgio Ivan Gil Braga. Maria LĂșcia explica que a histĂłria nĂŁo tem como recurso apenas documentos e que diversas sociedades, principalmente as tradicionais, utilizam-se da memĂłria, da dança e do canto para elaborar a sua histĂłria. Nas sociedades ditas modernas, a prĂĄtica de se transmitir a tradição por meio da oralidade fica mais difĂcil em razĂŁo da enxurrada de informaçÔes dos meios de comunicação. Ă nesse ambiente que, segundo ela, nĂŁo sĂł os brasileiros, mas o mundo, contraditoriamente aos avanços das tecnologias comunicacionais, fica cada vez mais com a memĂłria curta. Confira a entrevista que ela concedeu ao jornalista Wilson Nogueira
Entrevista com Maria LĂșcia MontesÂ
Da Filosofia Ă Antropologia, a trajetĂłria de Maria LĂșcia Aparecida Montes une uma carreira docente de mais de trĂȘs dĂ©cadas na Universidade de SĂŁo Paulo a uma atuação comprometida com os movimentos sociais, principalmente no campo da educação popular. Produção intelectual e reflexĂŁo acadĂȘmica nunca estiveram desvinculadas, em seu trabalho, do contato direto com a comunidade e do interesse pelo modo popular de pensar a polĂtica.  Como conseqĂŒĂȘncia, principalmente, dos acontecimentos que marcara..
Dissemination of information on visceral leishmaniasis from schoolchildren to their families: a sustainable model for controlling the disease
a multicenter study
(1) Background: The Commercial Kit SIRE NitrataseÂź PlastLabor, is a drug susceptibility test kit used to detect Mycobacterium tuberculosis resistance to first-line TB treatment drugs. The present study aimed at evaluating its performance in a multicenter study. (2) Methods: To determine its accuracy, the proportion methods in Lowenstein Jensen medium or the BACTECTMMGITTM960 system was used as a gold standard. (3) Results: The study revealed that the respective accuracies of the kit with 190 M. tuberculosis clinical isolates, using the proportion methods in Lowenstein Jensen medium or BACTECTMMGITTM960 system as a gold standard, were 93.9% and 94.6%, 96.9% and 94.6%, 98.0% and 97.8%, and 98.0% and 98.9%, for streptomycin, isoniazid, rifampicin, and ethambutol, respectively. (4) Conclusion: Thus, the kit can rapidly screen resistance to streptomycin, isoniazid, rifampicin, and ethambutol. Additionally, it does not require sophisticated equipment; hence, it can be easily used in the laboratories of low and middle income countries.publishersversionpublishe
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Background:
The ISARIC prospective multinational observational study is the largest cohort of hospitalized patients with COVID-19. We present relationships of age, sex, and nationality to presenting symptoms.
Methods:
International, prospective observational study of 60â109 hospitalized symptomatic patients with laboratory-confirmed COVID-19 recruited from 43 countries between 30 January and 3 August 2020. Logistic regression was performed to evaluate relationships of age and sex to published COVID-19 case definitions and the most commonly reported symptoms.
Results:
âTypicalâ symptoms of fever (69%), cough (68%) and shortness of breath (66%) were the most commonly reported. 92% of patients experienced at least one of these. Prevalence of typical symptoms was greatest in 30- to 60-year-olds (respectively 80, 79, 69%; at least one 95%). They were reported less frequently in children (â€â18 years: 69, 48, 23; 85%), older adults (â„â70 years: 61, 62, 65; 90%), and women (66, 66, 64; 90%; vs. men 71, 70, 67; 93%, each Pâ<â0.001). The most common atypical presentations under 60 years of age were nausea and vomiting and abdominal pain, and over 60 years was confusion. Regression models showed significant differences in symptoms with sex, age and country.
Interpretation:
This international collaboration has allowed us to report reliable symptom data from the largest cohort of patients admitted to hospital with COVID-19. Adults over 60 and children admitted to hospital with COVID-19 are less likely to present with typical symptoms. Nausea and vomiting are common atypical presentations under 30 years. Confusion is a frequent atypical presentation of COVID-19 in adults over 60 years. Women are less likely to experience typical symptoms than men
Increased susceptibility to Strongyloides venezuelensis infection is related to the parasite load and absence of major histocompatibility complex (MHC) class II molecules
Detection of drug resistant Mycobacterium Tuberculosis strains using kit SIRE NitrataseÂź: a multicenter study
This research was funded by MINAS GERAIS STATE RESEARCH SUPPORT FOUNDATION (FAPEMIG),
grants numbers 65/10 and CDS-APQ-03266-13, and by NATIONAL COUNCIL FOR SCIENTIFIC AND
TECHNOLOGICAL DEVELOPMENT (CNPQ) grants numbers 310174/2014-7 and 446796/2014-0.Federal University of Minas Gerais. Faculty of Medicine. Mycobacteria Research Laboratory. Belo Horizonte, MG, Brazil.Federal University of Minas Gerais. Faculty of Medicine. Mycobacteria Research Laboratory. Belo Horizonte, MG, Brazil.Federal University of Minas Gerais. Faculty of Medicine. Mycobacteria Research Laboratory. Belo Horizonte, MG, Brazil.Federal University of Minas Gerais. Faculty of Medicine. Mycobacteria Research Laboratory. Belo Horizonte, MG, Brazil.Federal University of Minas Gerais. Faculty of Pharmacy. Department of Social Pharmacy. Belo Horizonte, MG, Brazil.Federal University of Minas Gerais. Veterinary School. Department of Preventive Veterinary Medicine. Belo Horizonte, MG, Brazil.Federal University of Rio Grande. Faculty of Medicine. Laboratory of Mycobacteria. Rio Grande, RS, Brazil.Federal University of Rio Grande. Faculty of Medicine. Laboratory of Mycobacteria. Rio Grande, RS, Brazil.Federal University of Rio Grande. Faculty of Medicine. Laboratory of Mycobacteria. Rio Grande, RS, Brazil.MinistĂ©rio da SaĂșde. Secretaria de VigilĂąncia em SaĂșde. Instituto Evandro Chagas. Ananindeua, PA, Brasil.Tropical Medicine Foundation Dr. Heitor Vieira Dourado. Manaus, AM, Brazil.Tropical Medicine Foundation Dr. Heitor Vieira Dourado. Manaus, AM, Brazil.Federal University of Rio de Janeiro. Institute of Chest Diseases. Clementino Fraga Filho University Hospital. Rio de Janeiro, RJ, Brazil.Federal University of Rio de Janeiro. Institute of Chest Diseases. Clementino Fraga Filho University Hospital. Rio de Janeiro, RJ, Brazil.Federal University of Grande Dourados. Faculty of Health Sciences.
Dourados, MS, Brazil / Oswaldo Cruz Foundation. Campo Grande, Mato Grosso do Sul, MS, Brazil.Adolfo Lutz Institute. Bacteriology Center. Tuberculosis and Mycobacteriosis Center. SĂŁo Paulo, SP, Brazil.Adolfo Lutz Institute. Bacteriology Center. Tuberculosis and Mycobacteriosis Center. SĂŁo Paulo, SP, Brazil.Adolfo Lutz Institute. Bacteriology Center. Tuberculosis and Mycobacteriosis Center. SĂŁo Paulo, SP, Brazil.State Secretariat of Health of Rio Grande do Sul. State Center for Health Surveillance. Center for Scientific and Technological Development. Porto Alegre, RS, Brazil.State Secretariat of Health of Rio Grande do Sul. State Center for Health Surveillance. Center for Scientific and Technological Development. Porto Alegre, RS, Brazil.Oswaldo Cruz Foundation. National Institute of Infectology Evandro Chagas. Laboratory of Bacteriology and Bioassays of Rio de Janeiro. Rio de Janeiro, RJ, Brazil.Sergio Arouca National Public Health School. Professor HĂ©lio Fraga Reference Center. Rio de Janeiro, RJ, Brazil.Sergio Arouca National Public Health School. Professor HĂ©lio Fraga Reference Center. Rio de Janeiro, RJ, Brazil.Nova University of Lisbon. Institute of Hygiene and Tropical Medicine. Medical Microbiology Unit, Global Health and Tropical Medicine. Lisboa, Portugal.Nova University of Lisbon. Institute of Hygiene and Tropical Medicine. Medical Microbiology Unit, Global Health and Tropical Medicine. Lisboa, Portugal.Federal University of Rio de Janeiro. Faculty of Medicine. Tuberculosis Research Center. Rio de Janeiro, RJ, Brazil.Background: The Commercial Kit SIRE NitrataseÂź PlastLabor, is a drug susceptibility test kit
used to detect Mycobacterium tuberculosis resistance to first-line TB treatment drugs. The present study
aimed at evaluating its performance in a multicenter study. (2) Methods: To determine its accuracy, the
proportion methods in Lowenstein Jensen medium or the BACTECTMMGITTM960 system was used as a gold
standard. (3) Results: The study revealed that the respective accuracies of the kit with 190 M. tuberculosis
clinical isolates, using the proportion methods in Lowenstein Jensen medium or BACTECTMMGITTM960
system as a gold standard, were 93.9% and 94.6%, 96.9% and 94.6%, 98.0% and 97.8%, and 98.0% and
98.9%, for streptomycin, isoniazid, rifampicin, and ethambutol, respectively. (4) Conclusion: Thus, the kit can
rapidly screen resistance to streptomycin, isoniazid, rifampicin, and ethambutol. Additionally, it does not
require sophisticated equipment; hence, it can be easily used in the laboratories of low and middle income
countries